A pilot study of factors associated with glycaemic control in adults with Type 1 diabetes mellitus on insulin pump therapy
- PMID: 26484625
- DOI: 10.1111/dme.13001
A pilot study of factors associated with glycaemic control in adults with Type 1 diabetes mellitus on insulin pump therapy
Abstract
Aims: To identify the knowledge and management factors associated with glycaemic control among adults with Type 1 diabetes mellitus treated with insulin pump therapy.
Methods: A cross-sectional study of adults with Type 1 diabetes mellitus on insulin pump therapy for at least 12 months (n = 50, 18-70 years old) was undertaken between December 2013 and May 2014. A new questionnaire was developed to evaluate participants' knowledge and management related to insulin pump therapy, and were correlated with insulin pump data, HbA1c and frequency of hypoglycaemia.
Results: Participants who changed their insulin pump settings when indicated had significantly better glycaemic control than those who did not (P = 0.04). Multivariate logistic regression analysis found that better overall insulin pump therapy management was a significant predictor of better glycaemic control (odds ratio 4.45, 95% confidence interval 1.61-12.3; P = 0.004) after adjusting for potential confounders including age, gender, duration of diabetes and insulin pump therapy. However, overall insulin pump therapy knowledge was not a significant predictor of glycaemic control (P = 0.058). There was no significant association between frequency of hypoglycaemia and insulin pump therapy knowledge or management.
Conclusions: We identified some key knowledge and management factors associated with glycaemic control in adults with Type 1 diabetes mellitus on insulin pump therapy using a newly designed questionnaire. The pilot study assessed the clinical utility of this evaluation tool, which may facilitate provision of targeted education to insulin pump therapy users to achieve optimal glycaemic control.
© 2015 The Authors. Diabetic Medicine © 2015 Diabetes UK.
Similar articles
-
Implications of Predictive Low-Glucose Management System in Hybrid of Full Closed Loop System.Diabetes Technol Ther. 2016 Jul;18(7):408-9. doi: 10.1089/dia.2016.0227. Diabetes Technol Ther. 2016. PMID: 27379979 No abstract available.
-
Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with Type 1 diabetes.Diabet Med. 2015 Nov;32(11):1453-9. doi: 10.1111/dme.12869. Epub 2015 Aug 19. Diabet Med. 2015. PMID: 26213236
-
Continuous subcutaneous insulin infusion (CSII) therapy at Derby Teaching Hospitals: sustained benefits in glucose control.Diabet Med. 2017 Aug;34(8):1154-1157. doi: 10.1111/dme.13367. Epub 2017 May 16. Diabet Med. 2017. PMID: 28430381
-
Continuous subcutaneous insulin infusion: Special needs for children.Pediatr Diabetes. 2017 Jun;18(4):255-261. doi: 10.1111/pedi.12491. Epub 2017 Apr 20. Pediatr Diabetes. 2017. PMID: 28425167 Review.
-
Insulin Pumps.Diabetes Technol Ther. 2017 Feb;19(S1):S19-S26. doi: 10.1089/dia.2017.2503. Diabetes Technol Ther. 2017. PMID: 28192024 Review. No abstract available.
Cited by
-
Simulation Platform Development for Diabetes and Technology Self-Management.J Diabetes Sci Technol. 2022 Nov;16(6):1451-1460. doi: 10.1177/19322968211029303. Epub 2021 Jul 22. J Diabetes Sci Technol. 2022. PMID: 34293963 Free PMC article.
-
Insulin Pump Therapy: Patient Practices and Glycemic Outcomes.J Diabetes Sci Technol. 2018 Nov;12(6):1250-1251. doi: 10.1177/1932296818778869. Epub 2018 May 29. J Diabetes Sci Technol. 2018. PMID: 29808716 Free PMC article. No abstract available.
-
Self-Reported Compensation Techniques for Carbohydrate, Exercise, and Alcohol Behaviors in Patients With Type 1 Diabetes on Insulin Pump Therapy.J Diabetes Sci Technol. 2018 Mar;12(2):412-414. doi: 10.1177/1932296817718848. Epub 2017 Jul 5. J Diabetes Sci Technol. 2018. PMID: 28677414 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical